Mphasis Limited has made a regulatory disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The ESOP Compensation Committee approved on October 10, 2026 the grant of Employee Stock Options (Options) under the Employee Stock Option Plan 2016 (ESOP 2016) and Restricted Stock Units (RSUs) under the Restricted Stock Units Plan 2021 (RSU Plan 2021) to eligible employees.
ESOP 2016 Grant Details:
- Number of Options Granted: 64,434 Stock Options
- Grant Date: October 10, 2026
- Exercise Price: ₹2,300 per Option
- Vesting Period: 5 years from the date of grant
- Exercise Period: 60 calendar months from respective vesting dates
- Each Option entitles the holder to apply for one equity share of the Company of ₹10 each
RSU Plan 2021 Grant Details:
- Number of RSUs Granted: 43.144 RSUs
- Grant Date: October 10, 2026
- Exercise Price: ₹10 per RSU
- Vesting Period: Equal proportion over 4 years from date of grant
- Exercise Mechanism: Automatic Exercise for most employees, with shares settled by Mphasis Employees Benefit Trust upon vesting
- RSU Grantees (except US employees subject to US Internal Revenue Code) can elect for automatic exercise or exercise by notice
- For non-automatic exercise: 60 calendar months exercise period from respective vesting dates
- Each RSU entitles the holder to apply for one equity share of the Company of ₹10 each
Both plans (ESOP 2016 and RSU Plan 2021) were previously submitted to Stock Exchanges at the time of obtaining in-principle approval.
The disclosure was signed by Mayank Verma, SVP and Company Secretary (Membership No.: ACS 18776) and will be available on the company website at www.mphasis.com.